Need professional-grade analysis? Visit stockanalysis.com
$1.42B
N/A
489
N/A
Ardelyx Inc (ARDX) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $6.45, up 2.71% from the previous close.
Over the past year, ARDX has traded between a low of $3.28 and a high of $7.99. The stock has gained 34.1% over this period. It is currently 19.3% below its 52-week high.
Ardelyx Inc has a market capitalization of $1.42B.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Side-by-side comparison against top Healthcare peers.